Glycated hemoglobin predicts all-cause, cardiovascular, and cancer mortality in people without a history of diabetes undergoing coronary angiography.

Increased glycated hemoglobin was significantly correlated with higher cancer mortality ( Table 2 ).When fasting glucose was included as an additional covariate, the association of the glycated hemoglobin categories with cancer mortality reached borderline significance ( Table 2 ).

also in 370 other papers

The relationship of the fasting glucose categories with cancer mortality did not reach statistical significance ( Table 3 ).

also in 111,027 other papers